Allogene Therapeutics, Inc. · NASDAQ:ALLO
FMR LLC reported a 11.30% stake in Allogene Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 12, 2025
FMR LLC reported a 11.30% stake in Allogene Therapeutics, Inc., 23,771,995 shares, as a passive investor on Dec 31, 2024. Filed Feb 12, 2025 (Schedule 13G/A).
- Stake
- 11.30%
- Shares
- 23,771,995
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| FMR LLC | 11.30% | 23,771,995 |
| Abigail P. Johnson | 11.30% | 23,771,995 |
Source
Related
- Allogene Therapeutics, Inc.
- FMR LLC
- Allogene Therapeutics, Inc. shareholders
- Schedule 13G/A · FMR LLC · Mar 7, 2025
- Schedule 13D/A · Tpg Gp A, LLC · Sep 30, 2026
- Form 4 · Douglas Earl Martin · Aug 25, 2026
- Schedule 13G/A · Frazier Life Sciences Public Fund, L.P. · Aug 14, 2026
- Schedule 13G/A · Arie Belldegrun, M.D. · Aug 7, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026